SCHEMBL29587405

SCHEMBL29587405

Cc1ccc2cccc(S(=O)(=O)NC(=O)c3cc4c(OC(F)F)cc(C5CC5)cc4o3)c2n1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.37
TSHR P16473 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TP53 P04637 2/20 0.37
POLB P06746 2/20 0.37
USP2 O75604 1/20 0.37
PTGER4 P35408 3/20 0.36
SLC40A1 Q9NP59 2/20 0.34
NFKBIA P25963 1/20 0.34
RELA Q04206 1/20 0.34
PDE4D Q08499 1/20 0.33
CFTR P13569 3/20 0.33
MAT2A P31153 1/20 0.32
ALDH1A1 P00352 2/20 0.32
LMNA P02545 1/20 0.32
THRB P10828 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24313957 1.00 HSD17B10 (0.37) HSD17B10TSHRSMN1; SMN2TP53POLB
SCHEMBL24314295 0.87 HSD17B10 (0.40) HSD17B10TSHRSMN1; SMN2TP53POLB
SCHEMBL29587382 0.87 HSD17B10 (0.40) HSD17B10TSHRSMN1; SMN2TP53POLB
SCHEMBL29588270 0.85 HSD17B10 (0.39) HSD17B10TSHRSMN1; SMN2TP53POLB
SCHEMBL29587778 0.84 HSD17B10 (0.39) HSD17B10TSHRSMN1; SMN2TP53POLB
SCHEMBL24314312 0.84 HSD17B10 (0.39) HSD17B10TSHRSMN1; SMN2TP53POLB
SCHEMBL24313958 0.82 PDE4D (0.33) HSD17B10TSHRSMN1; SMN2PDE4DMAT2A
SCHEMBL24314201 0.81 PTGER4 (0.39) TSHRSMN1; SMN2TP53PTGER4ALDH1A1
SCHEMBL24313769 0.80 PTGER4 (0.38) POLBPTGER4PDE4DALDH1A1GAA
SCHEMBL29588225 0.80 PTGER4 (0.38) POLBPTGER4PDE4DALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229045-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute Inc. (US) 2023-08-23 EP claimed
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO claimed
EP-4229045-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute Inc. (US) 2023-08-23 EP disclosed
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed